Scalar cross-relaxation detected in the NOESY spectra of oxazolidines and thiazolidines by Panduwawala, Tharindi D. et al.
Scalar Cross-Relaxation Detected in the NOESY Spectra of
Oxazolidines and Thiazolidines
Tharindi D. Panduwawala,†,§ Laia Josa-Cullere,́†,§ Ilya Kuprov,‡ Barbara Odell,† Mark G. Moloney,*,†
and Timothy D. W. Claridge*,†
†Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansﬁeld Road, Oxford OX1 3TA, U.K.
‡School of Chemistry, University of Southampton, Highﬁeld Campus, Southampton SO17 1BJ, U.K.
*S Supporting Information
ABSTRACT: Anomalous cross-peaks observed in the NOESY
spectra of 2,4-disubstituted thiazolidines and oxazolidines that cannot
be attributed to classical dipolar NOE or chemical exchange peaks
have been investigated experimentally and computationally and have
been shown to arise from scalar cross-relaxation of the ﬁrst kind. This
process is stimulated by the relatively slow modulation of scalar
couplings and, for the systems studied, arises from slow on−oﬀ
proton exchange of the amino nitrogen, a process inﬂuenced by
solution temperature, acidity, and concentration. The mechanism is
likely to be signiﬁcant for many systems in which proton exchange
occurs on the millisecond time scale, and misinterpretation of these
cross-peaks may lead to erroneous conclusions should their true
origins not be recognized.
■ INTRODUCTION
Nitrogen heterocycles comprise the core structural subunit in
many alkaloids, and impart wide ranging biological and
pharmaceutical activities.1,2 We have been interested in the
elaboration of amino acid esters 1−3 to oxazolidines/
thiazolidines cis-4 and trans-4 (where cis and trans deﬁnes the
relative stereochemistry for the two positions adjacent to the ring
nitrogen) and their use in turn as templates to direct aldol and
Dieckmann ring annulation processes (Scheme 1).3−5 This
chemistry may be applied to systems derived from serine 1,4,5
threonine 2,6,7 and cysteine 3,8 and the success of these processes
critically depends on ring−chain tautomerism,9−12 which
permits equilibration between cis and trans diastereomers 4,
ultimately leading to the more stable product in which both
substituents are pseudoequatorial, which is especially preferred
when R′ = t-Bu; this approach has shown synthetic value in the
construction of antibacterial chemical libraries.13
During the synthesis of the oxazolidines and thiazolidines,
prepared using literature protocols,4−8 mixtures of cis and trans
diastereomers 4 were produced in ratios of ∼1:1, which were
diﬃcult to separate by standard column chromatography. In the
course of assigning the relative stereochemistry of these isomers,
we were surprised to observe anomalous cross-peaks in 2D
NOESY spectra that could not be explained by conventional
analysis, as exempliﬁed for 4d (Figure 1). This spectrum is
unusual because in addition to the negative cross-peaks (colored
blue) between CH protons indicative of the classical through-
space nuclear Overhauser eﬀect14,15 a number of strong positive
cross-peaks (colored red) are also observed. Conventionally, for
small molecules that do not aggregate, such peaks would be
suggestive of chemical exchange occurring between correlated
protons,16 but here these are between protons that cannot
possibly exchange with each other. Herein we rationalize the
origin of these eﬀects as arising from scalar cross-relaxation of the
ﬁrst kind (SCRFK), a process shown to be driven by NH proton
exchange in these molecules. We believe it is likely that others
will observe similar eﬀects in NOE spectra in the presence of
proton exchange and we present our investigations on the
appearance of this eﬀect in the title compounds to draw wider
attention to this phenomenon.
■ RESULTS AND DISCUSSIONS
In a previous publication,17 anomalous NOESY cross-peaks
similar to those in Figure 1 but observed for C-substituted
aziridines could not be explained by dipolar cross-relaxation or
chemical exchange and were shown, through experimental and
computational studies, to arise from scalar relaxation of the ﬁrst
kind. The requirement for the associated scalar cross-relaxation
process to occur, and be able to eﬀectively compete with the
dipolar cross-relaxation that is responsible for the classical NOE,
is a modulation, on a millisecond time scale, of the coupling
constant between J-coupled protons, such that the rate of
longitudinal scalar cross-relaxation (expressed in eq 1) becomes
signiﬁcant:17,18
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This expression shows that the cross-relaxation rate depends
upon the size of modulation of scalar coupling constant (ΔJ), its
rate of change (reﬂected in the lifetime of exchanging states τex)
and the frequency separation between the J-coupled protons
(ω1−ω2) in the 1H spectrum. The eﬀect is expected to be most
pronounced for coupled protons with similar chemical shifts and
where large modulations of coupling constants may occur.
Notably, it gives rise to cross-peaks that have opposite sign to the
NOEs typically observed for small molecules.
The NOESY spectrum of 4d could be calculated theoretically
using the Spinach simulation program19−21 to reproduce the
anomalous cross peaks of Figure 1 only when scalar cross-
relaxation was included between the NH protons and their J-
coupled neighbors H2 and H4 (Figure 2); without this term only
classical dipolar NOEs were reproduced (see Supporting
Information for details and Figure S1).
In the case of the aziridines,17 this scalar cross-relaxation
process was shown theoretically to arise from the modulation of
1H−1H J-couplings of NH protons through conformational
transitions involving nitrogen inversion. This is known to be
relatively slow in aziridines due to the high inversion energy
barriers involved (∼70 kJ mol−1), and hence gave rise to J-
modulation rates appropriate for SCRFK to be operational and
able to compete with the dipolar NOE.
We could ﬁnd no reports on nitrogen inversion barriers in
thiazolidines and oxazolidines in which the nitrogen is not fully
substituted, although the free energy of activation for nitrogen
inversion inN-methylthiazolidine is reported to be 35.9 kJ mol−1
(at the exchange coalescence temperature of 173 K).22 The
inversion barrier in pyrrolidine is 25 kJ mol−1,23 very much lower
than in aziridines, and likely to be similar to those in oxazolidines
and thiazolidines such as 4. DFT calculations of the nitrogen
inversion barrier do indeed suggest this to be the case (see
Supporting Information), which places the nitrogen inversion
time scale in the microsecond region at ambient temperatures.
Such rates are too high to give rise to signiﬁcant scalar cross-
relaxation, and thus nitrogen inversion is not an appropriate
mechanism to yield cross-peaks for the oxazolidine and
thiazolidine systems which have NH proton scalar couplings of
<15 Hz. Consistent with the absence of slow nitrogen inversion,
only a single set of resonances was ever observed experimentally
for each diastereoisomer of 4d studied over a wide temperature
range (193 to 298 K), and resonances from separate invertomers
were never detected (in contrast to the aziridines where these
were fully resolved in 1HNMR spectra at 193 K17). This suggests
that the process by which J-couplings are modulated to give rise
Scheme 1. Thiazolidines (X = S) and Oxazolidines (X = O) Derived from Amino Acids and Aldehydes and the Corresponding
Product Ratios in the Systems Studied by NMR
Figure 1. 1H−1H NOESY spectrum of 4d as 1.6:1 cis:trans mixture
(CDCl3, 298 K, 500 MHz, 800 ms mixing time), showing anomalous
strong positive cross-peaks (red) between the NH protons and those of
the neighboring CH groups (boxed region).
Figure 2. Simulated 1H−1H NOESY spectrum of 4d (800 ms mixing
time), exactly reproduces the positive cross-peaks of Figure 1 only when
scalar cross-relaxation of the ﬁrst kind is considered between the amino
protons and their J-coupled neighbors. Molecular geometries were
obtained fromDFT calculations, while chemical shifts and J-couplings of
the individual cis and trans isomers were extracted from the experimental
1D NMR spectra. The proton exchange rate at the nitrogen center was
set to 500 s−1, overall rotational correlation time to 30 ps, nitrogen
inversion correlation time to 100 μs, andmodulation depth of J-coupling
between the amino proton and the protons at C2 and C4 was set to 15
Hz (see main text for discussion of these parameters).
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to scalar cross-relaxation for 4d must involve a diﬀerent
mechanism than direct nitrogen NH inversion.
Similar NOESY spectra exhibiting scalar cross-relaxation peaks
between NH protons and adjacent CH protons were observed
for variously substituted thiazolidines and oxazolidines when
studied at room temperature (see Figure S2). It was noticeable
that the appearance of these cross-peaks was correlated with the
presence of broad NH resonances without resolved J-coupling
Figure 3. 1H−1H NOESY spectrum (800 ms mixing time) of compound 4d. (a) Mixture of cis/trans diastereoisomers in 1.6:1 ratio in CD2Cl2 at 193 K,
showing only dipolar NOE (blue) and chemical exchange (red) cross-peaks. (b) A simulated NOESY spectrum (τc = 300 ps), calculated using exchange
rate constants of 0.25 and 0.5 s−1 (for cis and trans isomers, respectively) which reproduces all observed cross-peaks.
Scheme 2. Likely Proton Exchange Mechanisms in Thiazolidines (X = S) and Oxazolidines (X = O)a
a(a) acid catalysed proton exchange; (b) bimolecular proton exchange.
Figure 4. Variable temperature 1H NMR spectra of 4d in dried and degassed CD2Cl2 at 90 mM. The rate constants for two-site exchange between NH
protons of the two diastereoisomers were determined by line shape ﬁtting, with the lower rate constant listed.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.6b00458
J. Org. Chem. 2016, 81, 4142−4148
4144
structure for both cis and trans isomers; when the coupling ﬁne
structures of these resonances were well resolved, the anomalous
cross-peaks were not seen. For example, the 1H spectrum of 4d
recorded at 193 K showed clear NH coupling structure and the
NOESY spectrum contained only intramolecular dipolar NOE
peaks and chemical exchange peaks between the amino protons
of the separate diastereoisomers, indicating these undergo slow
intermolecular exchange (Figure 3). This suggests a likely
process to cause modulation of J-couplings in the ﬁve-membered
ring is a nitrogen protonation−deprotonation process, which
could involve both acid-catalyzed and bimolecular pathways, in
which water may also play a contributing role (Scheme 2). In the
context of the SCRFK process, this would lead to variation of the
scalar coupling since the incoming proton spin-state is
uncorrelated with those of the remaining protons in the ring, a
process also known to give rise to a loss of coupling structure, and
often referred to as “exchange decoupling”. This process is clearly
apparent in the variable temperature spectra of 4d (Figure 4)
where, as the NH resonances broaden, their coupling structure
with the H2 and H4 resonances is progressively lost. Lineshape
simulations of the spectra (Figure S3) provided estimates of the
NH exchange rates between cis/trans diastereoisomers, which
would likely be similar to those for exchange between similar
stereoisomers (cis/cis or trans/trans) that would not normally be
apparent in 1H NMR spectra. These rates were used in
simulations of NOESY spectra of 4d to demonstrate the
dependence on the scalar relaxation process on kinetic
parameters (Figure S4), and these data clearly illustrate the
progressive increase in SCRFK cross-peaks as the exchange rate
increases and the NH J-coupling structure collapses. These data
suggest that at rates below ∼50 s−1, SCRFK becomes
inconsequential, while for rates at or above ∼200 s−1 (i.e.,
similar to those observed experimentally under ambient
temperature conditions; Figure 4) this process is signiﬁcant
and gives rise to strong scalar cross-relaxation cross-peaks, as
seen in Figure 1. In accord with this behavior, we have also
observed that in situations when NH peaks display well-resolved
multiplet structures and no SCRFK cross-peaks in NOESY
spectra, their appearance can be stimulated by raising the sample
temperature to increase exchange rates such that NH coupling
structure collapses. This may also be accompanied by evidence
for NH exchange with residual water in the solvent (classical
chemical exchange cross-peaks), as was observed for 4g in
toluene (Figure S5). It is also worth noting that for the chemical
systems described here, the HN-H4 SCRFK cross-peaks always
appear more intense than those for HN-H2 correlations, despite
the similar J-coupling constants and the inﬂuence of identical
exchange processes. This is a consequence of the smaller
chemical shift separation in the case of HN-H4 and is consistent
with the behavior anticipated from eq 1.
The proposed protonation−deprotonation cross-relaxation
mechanism has been previously reported. Over 40 years ago,
Fukumi et al. concluded that J-couplings were responsible for the
sign change observed in the cross-relaxation rate between the
OH and the CH protons in methanol24 and ethanol25 when acid
concentration was varied. The corresponding theory originates
from 1956,18 but, until recently,17 it appears that clear
experimental manifestations of the process in molecules larger
than HF, methanol, and ethanol are rare enough (or unusual
enough) for the process to be commonly overlooked during
NOESY data analysis. We believe this to be the ﬁrst reported
evidence for NH proton exchange yielding cross-peaks in
NOESY spectra due to scalar cross-relaxation of the ﬁrst kind.
Our investigations into these systems also demonstrated the
appearance of these eﬀects to be acutely sensitive to solution
conditions, and speciﬁcally those that may inﬂuence NH
exchange rates. For example, diﬀerent batches of the CD2Cl2
solvent (prepared in diﬀerent countries) gave diﬀerent results:
those that showed coalesced NH signals and SCRFK peaks in
NOESY were suspected to contain traces of acid, whereas those
that did not show these peaks were presumed to be less acidic.
Consequently, the addition of trace amounts of deuterated acetic
acid to the latter solutions of 4d (0.01% v/v) was able to
reintroduce these cross-peaks (Figure S6). The inﬂuence of
traces of acid in sample workup procedures was also investigated
in detail for 4d where samples were dissolved in EtOAc and
Figure 5. Concentration dependence of the NMR spectra of compound 4d at 298 K in CD2Cl2. (a) 8 mM; (b) 90 mM; (c) 270 mM; (d) 450 mM; (e)
900 mM.
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washed with buﬀer at pH 5, 7, and 9 (see details in Supporting
Information). Only the sample subjected to the pH 5 buﬀer gave
rise to the SCRFK cross-peaks, while those from the higher pH
buﬀers did not (Figure S7). Scalar cross-relaxation peaks were
observed across a range of solvents including CD2Cl2, CDCl3,
C6D6, and toluene, although the exception was DMSO which
appeared to inhibit these peaks, likely due to hydrogen-bonding
perturbing the NH exchange process.
The likely involvement of bimolecular exchange was also seen
to inﬂuence the proton spectrum of 4d as a function of solution
concentration (Figure 5). An increase was seen to lead to
broadening of the NH resonance of both isomers with
corresponding exchange decoupling of neighboring protons,
indicative of an increase in exchange rate. Correspondingly,
scalar cross-relaxation cross-peaks were observed only at the
higher concentration for this sample. Slight shift changes are also
apparent in the spectra of Figure 5 as a function of concentration,
most notably for the NH and the adjacent CH protons, which
suggests association, potentially through intermolecular hydro-
gen bonding involving amino and carbonyl groups. Such
association may promote the bimolecular exchange process
and serve to enhance the appearance of scalar cross-relaxation.
Thus, sample concentration will also likely dictate conditions
under which scalar cross-relaxation peaks may be seen in NOESY
spectra when proton exchange is involved, alongside temperature
and solvent acidity.
■ CONCLUSIONS
The appearance of anomalous cross-peaks in the NOESY spectra
of oxazolidines and thiazolidines has been attributed to scalar
cross-relaxation of the ﬁrst kind that arises when the J-couplings
between correlated protons are slowly modulated. These cross-
peaks have opposite sign to positive NOEs and an appearance
similar to chemical exchange peaks, although they do not arise
between mutually exchanging protons. For these systems, they
are shown to arise from proton on−oﬀ exchange at the amino
nitrogen which leads to modulation of proton scalar couplings,
and their appearance is therefore sensitive to solution conditions
that will inﬂuence this exchange rate, including sample
temperature, solution acidity, and solute concentration. The
presence of such peaks in (1D and 2D)NOESY spectra will likely
occur in any system in which scalar couplings are modulated at an
appropriate rate (on the millisecond time scale), with likely
mechanisms including conformational interconversion, nitrogen
inversion, and proton exchange.
■ EXPERIMENTAL SECTION
Synthesis. General Procedure for the Synthesis of Oxazolidine
and Thiazolidine Compounds.26 To the relevant methyl ester
hydrochloride (1.0 equiv) in petroleum ether, triethylamine (1.5
equiv) and aldehyde (1.2 equiv) were added. The mixture was heated at
reﬂux with continuous removal of water using a Dean−Stark head for 18
h. The white precipitate was then ﬁltered and washed with Et2O. The
combined ﬁltrates were concentrated under reduced pressure to give the
oxazolidine or thiazolidine. All aryl substituted thiazolidines were
puriﬁed by ﬂash column chromatography (SiO2, EtOAc/Petroleum
ether).
Methyl (2RS,4S)-2-(tert-Butyl)-1,3-oxazolidine-4-carboxylate
(4a).27,28 Yield (5.85 g, 97%); yellow oil; inseparable 1.4:1 cis and
trans diastereomers. Rf (85% EtOAc in DCM) 0.64;
1H NMR (400
MHz, CDCl3) major isomer (cis): δ 4.07 (s, 1H, H2), 3.89−3.97 (m, 2H,
H5A + H4), 3.76 (s, 3H, CO2CH3), 3.68−3.72 (m, 1H, H5B), 2.61 (br s,
1H, NH, averaged with trans isomer NH), 0.98 (s, 9H, C(CH3)3); minor
isomer (trans): 4.32 (s, 1H, H2), 4.11 (app t, 1H, J = 7.6 Hz, H5A),
3.89−3.97 (m, 1H, H4), 3.74 (s, 3H, CO2CH3), 3.68−3.72 (m, 1H,
H5B), 2.61 (br s, 1H, NH,- averaged with cis isomer NH), 0.91 (s, 9H,
C(CH3)3);
13C{1H} NMR (100 MHz, CDCl3) major isomer (cis): δ
173.0 (CO2CH3), 100.0 (C2), 68.4 (C4), 59.6 (C5), 52.7 (CO2CH3),
33.3 (C(CH3)3), 25.3 (C(CH3)3); minor isomer (trans): 173.2
(CO2CH3), 99.3 (C2), 69.0 (C4), 59.5 (C5), 52.5 (CO2CH3), 34.6
(C(CH3)3), 25.0 (C(CH3)3); IR (neat) νmax/cm
−1 3316, 2955, 1740;
HRMS (TOF, ESI+) m/z: [M+H]+ Calcd for C9H18NO3 188.1281;
Found 188.1285.
Methyl (2RS,4S,5R)-2-(tert-Butyl)-5-methyl-1,3-oxazolidine-4-car-
boxylate (4b). Yield (1.84 g, 77%); yellow oil; inseparable 1:1
diastereomers. Rf (50% EtOAc in DCM) 0.64;
1H NMR (400 MHz,
CDCl3) (2R,4S,5R) isomer: δ 4.29 (s, 1H, H2), 3.78−3.88 (m, 1H, H5),
3.75 (s, 3H, CO2CH3), 3.46 (d, 1H, J = 7.2 Hz, H4), 2.69 (br s, 1H, NH,
averaged with 2S,4S,5R isomer NH), 1.33 (d, 3H, J = 6.0 Hz, C(5)CH3),
0.97 (s, 9H, C(CH3)3); (2S,4S,5R) isomer: 4.38 (s, 1H, H2), 3.78−3.88
(m, 1H, H5), 3.77 (s, 3H, CO2CH3), 3.36 (d, 1H, J = 7.2 Hz, H4), 2.69
(br s, 1H, NH, averaged with 2R,4S,5R isomer NH), 1.37 (d, 3H, J = 6.0
Hz, C(5)CH3), 0.90 (s, 9H, C(CH3)3);
13C{1H} NMR (100 MHz,
CDCl3) (2R,4S,5R) isomer: δ 172.1 (CO2CH3), 98.9 (C2), 76.4 (C5),
65.9 (C4), 52.6 (CO2CH3), 34.7 (C(CH3)3), 24.9 (C(CH3)3), 20.0
(C(5)CH3); (2S,4S,5R) isomer: 172.8 (CO2CH3), 98.3 (C2), 77.4
(C5), 67.2 (C4), 52.5 (CO2CH3), 33.7 (C(CH3)3), 25.3 (C(CH3)3),
19.1 (C(5)CH3); IR (neat) νmax/cm
−1 3315, 2957, 1741; HRMS (TOF,
ESI+) m/z: [M+Na]+ Calcd for C10H19NNaO3 224.1257; Found
224.1266.
Methyl (2RS,4S)-2-(tert-Butyl)-1,3-thiazolidine-4-carboxylate
(4c).29 Yield (2.32 g, 98%); yellow oil; inseparable 2.6:1 cis and trans
diastereomers. Rf (75% EtOAc in DCM) 0.61;
1H NMR (500 MHz,
CDCl3) major isomer (cis): δ 4.43 (s, 1H, H2), 3.78 (dd, 1H, J = 9.7, 6.7
Hz, H4), 3.75 (s, 3H, CO2CH3), 3.23 (t, 1H, J = 10.2, 6.7 Hz, H5A), 2.65
(t, 1H, J = 10.0 Hz, H5B), 2.40 (br s, 1H, NH, averaged with trans isomer
NH), 1.04 (s, 9H, C(CH3)3); minor isomer (trans): 4.50 (s, 1H, H2),
4.11 (t, 1H, J = 6.0 Hz, H4), 3.72 (s, 3H, CO2CH3), 3.08 (t, 1H, J = 10.6,
6.4 Hz, H5A), 2.99 (dd, 1H, J = 10.6, 5.6 Hz, H5B), 2.40 (br s, 1H, NH,
averaged with cis isomer NH), 0.95 (s, 9H, C(CH3)3);
13C{1H} NMR
(100 MHz, CDCl3) major isomer (cis): δ 171.9 (CO2CH3), 81.9 (C2),
65.5 (C4), 52.5 (CO2CH3), 37.5 (C5), 34.1 (C(CH3)3), 27.1
(C(CH3)3); minor isomer (trans): 172.5 (CO2CH3), 79.9 (C2), 65.1
(C4), 52.5 (CO2CH3), 37.1 (C5), 36.0 (C(CH3)3), 26.7 (C(CH3)3); IR
(neat) νmax/cm
−1 3317, 2954, 1740; HRMS (TOF, ESI+) m/z: [M
+Na]+ Calcd for C9H17NNaO2S 226.0872; Found 226.0880.
Methyl (2RS,4R)-2-Phenyl-1,3-thiazolidine-4-carboxylate (4d).
Yield (2.37 g, 91%); colorless oil; inseparable 1.6:1 cis and trans
diastereomers; Rf (25% ethyl acetate in petroleum ether) 0.48;
1HNMR
(500 MHz, CDCl3) major isomer (cis): δ 7.56−7.47 and 7.41−7.31 (m,
5H, Ar−CH), 5.57 (s, 1H, H2), 3.99 (dd, 1H, J = 9.0, 7.0 Hz, H4), 3.80
(s, 3H, CO2CH3), 3.47 (dd, 1H, J = 10.43, 7.0 Hz, H5A), 3.12 (dd, 1H, J
= 10.3, 9.0 Hz, H5B), 2.70 (br. s, 1H, NH, averaged with trans isomer
NH); minor isomer (trans): δ 7.41−7.31 (m, 5H, Ar−CH), 5.82 (s, 1H,
H2), 4.22 (dd, 1H, J = 7.1, 5.8 Hz, H4), 3.79 (s, 3H, CO2CH3), 3.39 (dd,
1H, J = 10.6, 7.1 Hz, H5A), 3.21 (dd, 1H, J = 10.6, 5.8 Hz, H5B), 2.70 (br.
s, 1H, NH, averaged with cis isomer NH); 13C{1H} NMR (100 MHz,
CDCl3) major isomer (cis): δ 171.6 (CO2CH3), 138.2 (Ar−C), 128.7,
128.5, 127.5 (Ar-CH), 70.9 (C2), 64.3 (C4), 52.6 (CO2CH3), 39.2
(C5); minor isomer (trans): δ 172.2 (CO2CH3), 141.2 (Ar−C), 128.7,
127.9, 127.0 (Ar-CH), 72.6 (C2), 65.6 (C4), 52.6 (CO2CH3), 38.2
(C5); IR (neat) νmax/cm
−1 3314, 2952, 1736; HRMS (TOF, ESI+)m/z:
[M+Na]+ Calcd for C11H13NNaO2S 246.0559; Found 246.0563.
Methyl (2RS,4R)-2-(4-Bromophenyl)-1,3-thiazolidine-4-carboxy-
late (4e). Yield (5.60 g, 94%); colorless oil; inseparable 1.4:1 cis and
trans diastereomers; Rf (20% ethyl acetate in petroleum ether) 0. 23;
1H
NMR (500 MHz, C6D6) major isomer (cis): δ 7.39 (d, 2H, J = 8.5 Hz,
Ar−CH), 7.30 (d, 2H, J = 8.4 Hz, Ar−CH), 5.40 (s, 1H, H2), 3.87 (app
t, 1H, J = 7.9 Hz, H4), 3.70 (s, 3H, CO2CH3), 3.35 (dd, 1H, J = 10.4, 7.1
Hz, H5A), 3.00 (dd, 1H, J = 10.3, 8.9 Hz, H5B), 2.90−2.32 (br. s, 1H,
NH, averaged with trans isomer NH); minor isomer (trans): δ 7.34 (d,
2H, J = 8.5 Hz, Ar−CH), 7.26 (d, 2H, J = 8.4 Hz, Ar−CH), 5.66 (s, 1H,
H2), 4.03 (app t, 1H, J = 6.5 Hz, H4), 3.69 (s, 3H, CO2CH3), 3.27 (dd,
1H, J = 10.6, 7.1 Hz, H5A), 3.06 (dd, 1H, J = 10.6, 6.1 Hz, H5B), 2.90−
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2.32 (br. s, 1H, NH, averaged with cis isomer NH); 13C{1H} NMR (100
MHz, CDCl3) major isomer (cis): δ 171.4 (CO2CH3), 137.2, 122.5
(Ar−C), 131.7, 129.1 (Ar-CH), 71.0 (C2), 65.4 (C4), 52.6 (CO2CH3),
39.1 (C5); minor isomer (trans): δ 172.0 (CO2CH3), 140.5, 121.6 (Ar−
C), 131.3, 128.6 (Ar-CH), 69.8 (C2), 64.0 (C4), 52.5 (CO2CH3), 38.0
(C5); IR (neat) νmax/cm
−1 3313, 2951, 1737; HRMS (TOF, ESI+)m/z:
[M+H]+ Calcd for C11H13O2NBrS 301.9845 and 303.9824; Found
301.9841 and 303.9818.
Methyl (2RS,4R)-2-(4-Nitrophenyl)-1,3-thiazolidine-4-carboxylate
(4f).8 Yield (2.95 g, 94%); yellow oil; inseparable 0.8:1 cis and trans
diastereomers; Rf (25% ethyl acetate in petroleum ether) 0.20;
1HNMR
(500MHz, CDCl3) major isomer (trans): δ 8.15 (d, 2H, J = 8.8 Hz, Ar−
CH), 7.63 (d, 2H, J = 8.5Hz, Ar−CH), 5.88 (s, 1H, H2), 4.08 (app t, 1H,
J = 6.6 Hz, H4), 3.80 (s, 3H, CO2CH3), 3.39−3.35 (m, 1H, H5A), 3.16−
3.11(m, 1H, H5B), 2.65 (br. s, 1H, NH); minor isomer (cis): δ 8.20 (d,
2H, J = 8.8 Hz, Ar−CH), 7.69 (d, 2H, J = 8.5 Hz, Ar−CH), 5.60 (s, 1H,
H2), 4.02 (app t, 1H, J = 8.0 Hz, H4), 3.81 (s, 3H, CO2CH3), 3.48 (dd,
1H, J = 10.4, 7.0 Hz, H5A), 3.16−3.11 (m, 1H, H5B), 3.05 (br. s, 1H,
NH); 13C{1H} NMR (100 MHz, CDCl3) major isomer (trans): δ 171.7
(CO2CH3), 149.5, 145.5 (Ar−C), 127.5, 123.5 (Ar-CH), 69.0 (C2),
64.1 (C4), 52.6 (CO2CH3), 38.1 (C5); minor isomer (cis): δ 171.2
(CO2CH3), 147.7, 147.1 (Ar−C), 128.4, 123.7 (Ar-CH), 70.9 (C2),
65.3 (C4), 52.6 (CO2CH3), 39.0 (C5); IR (neat) νmax/cm
−1 3316, 1730,
1516, 1348; HRMS (TOF, ESI+) m/z: [M+Na]+ Calcd for
C11H12N2NaO4S 291.0410; Found 291.0405.
Methyl (2RS,4R)-2-(3-Vinylphenyl)-1,3-thiazolidine-4-carboxylate
(4g). Yield (5.60 g, 84%); colorless oil; inseparable 1.4:1 cis and trans
diastereomers; Rf (20% ethyl acetate in petroleum ether) 0. 43;
1HNMR
(400 MHz, CDCl3) major isomer (cis): δ 7.60−7.28 (m, 4H, Ar−CH),
6.79−6.69 (m, 1H, H1′), 5.86−5.75 (m, 1H, H2′B), 5.58 (d, 1H, J = 12.2
Hz, H2), 5.33−5.26 (m, 1H, H2′A), 4.07−3.97 (m, 1H, H4), 3.83 (s, 3H,
CO2CH3), 3.49 (dd, 1H, J = 10.3, 7.1 Hz, H5A), 3.14 (dd, 1H, J = 10.3,
9.1 Hz, H5B), 2.70 (app t, 1H, J = 12.2 Hz, NH); minor isomer (trans): δ
7.60−7.28 (m, 4H, Ar−CH), 6.79−6.69 (m, 1H, H1′), 5.86−5.75 (m,
2H, H2 + H2′B), 5.33−5.26 (1H, m, H2′A), 4.28−4.20 (m, 1H, H4),
3.82 (s, 3H, CO2CH3), 3.41 (dd, 1H, J = 10.5, 7.1 Hz, H5A), 3.23 (dd,
1H, J = 10.8, 5.9 Hz, H5B), 2.93−2.84 (1H, broad signal, NH); 13C{1H}
NMR (100MHz, CDCl3) major isomer (cis): δ 171.5 (CO2CH3), 138.3,
138.0 (Ar−C), 136.3 (C1′), 128.8, 126.8, 126.4, 125.3 (Ar-CH), 114.5
(C2′), 72.4 (C2), 65.5 (C4), 52.5 (CO2CH3), 39.1 (C5); minor isomer
(trans): δ 172.1 (CO2CH3), 141.4, 137.7 (Ar−C), 136.5 (C1′), 128.5,
126.3, 125.6, 124.8 (Ar-CH), 114.2 (C2′), 70.6 (C2), 64.2 (C4), 52.5
(CO2CH3), 38.0 (C5); IR (neat) νmax/cm
−1 3305, 2951, 1737; HRMS
(TOF, ESI+) m/z: [M+H]+ Calcd for C13H16O2NS 250.0896; Found
250.0890.
NMR Spectroscopy. NMR data were collected at 500 MHz (1H)
with sample temperatures over the range 193−373 K as stated. Samples
were dissolved in dry C6D6, CD2Cl2, DMSO-d6, or toluene-d8 and
characterized by 1H, COSY, edited-HSQC, and 13C NMR. 2D NOESY
spectra were collected using standard pulse programs (90-t1-90-τm-90-
Acq, without or with a purging bipolar gradient pulse pair (+G1[180]-
G1) at the midpoint of the mixing period, τm) with mixing times of 800
ms at the temperatures and in the solvents stated. For each data set, 8 or
16 transients were acquired for each of the 256 increments with 2K data
points per spectrum, using a recovery time of 2 s. Data were processed
typically as 1K × 1K data points using shifted squared-sinebell
apodization windows. Typical sample concentrations for NOE analyses
were in the range 8−450 mM. Probe temperature calibrations were
performed using neat methanol samples containing a trace of HCl
(below ambient) or with neat ethylene glycol (above ambient), and
experiments were performed with active correction of the sample
temperature set-points. Spectra were referenced to the residual 1H
solvent peak. 1H NMR line shape simulations were performed using the
gNMR30 or SPINACH19 programs.
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(12) Laźaŕ, L.; Göblyös, A.; Martinek, T. A.; Fülöp, F. J. Org. Chem.
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